BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1491697)

  • 1. Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor.
    Drucker DJ; Lee YC; Asa SL; Brubaker PL
    Mol Endocrinol; 1992 Dec; 6(12):2175-84. PubMed ID: 1491697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.
    Drucker DJ; Jin T; Asa SL; Young TA; Brubaker PL
    Mol Endocrinol; 1994 Dec; 8(12):1646-55. PubMed ID: 7535893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene.
    Brubaker PL; Lee YC; Drucker DJ
    J Biol Chem; 1992 Oct; 267(29):20728-33. PubMed ID: 1328210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region- and age-specific differences in proglucagon gene expression in the central nervous system of wild-type and glucagon-simian virus-40 T-antigen transgenic mice.
    Lee YC; Campos RV; Drucker DJ
    Endocrinology; 1993 Jul; 133(1):171-7. PubMed ID: 8319563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice.
    Drucker DJ
    Am J Physiol; 1994 Nov; 267(5 Pt 1):E629-35. PubMed ID: 7977712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine tumors.
    Ehrlich P; Tucker D; Asa SL; Brubaker PL; Drucker DJ
    Am J Physiol; 1994 Nov; 267(5 Pt 1):E662-71. PubMed ID: 7977716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas.
    Philippe J; Mojsov S; Drucker DJ; Habener JF
    Endocrinology; 1986 Dec; 119(6):2833-9. PubMed ID: 3536450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestine.
    Flock G; Drucker DJ
    Mol Endocrinol; 2002 Oct; 16(10):2349-59. PubMed ID: 12351699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
    Dhanvantari S; Brubaker PL
    Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor.
    Brubaker PL; Drucker DJ; Asa SL; Swallow C; Redston M; Greenberg GR
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3078-83. PubMed ID: 12107204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription.
    Hill ME; Asa SL; Drucker DJ
    Mol Endocrinol; 1999 Sep; 13(9):1474-86. PubMed ID: 10478839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
    Asa SL; Lee YC; Drucker DJ
    Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prohormone convertases in the tissue-specific processing of proglucagon.
    Dhanvantari S; Seidah NG; Brubaker PL
    Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pdx-1 is not sufficient for repression of proglucagon gene transcription in islet or enteroendocrine cells.
    Flock G; Cao X; Drucker DJ
    Endocrinology; 2005 Jan; 146(1):441-9. PubMed ID: 15471960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
    Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
    Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proglucagon processing in islet and intestinal cell lines.
    Tucker JD; Dhanvantari S; Brubaker PL
    Regul Pept; 1996 Apr; 62(1):29-35. PubMed ID: 8738879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.
    Ugleholdt R; Zhu X; Deacon CF; Ørskov C; Steiner DF; Holst JJ
    Endocrinology; 2004 Mar; 145(3):1349-55. PubMed ID: 14630721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells.
    Dhanvantari S; Izzo A; Jansen E; Brubaker PL
    Endocrinology; 2001 Jan; 142(1):37-42. PubMed ID: 11145564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
    Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro.
    Lui EY; Asa SL; Drucker DJ; Lee YC; Brubaker PL
    Endocrinology; 1990 Jan; 126(1):110-7. PubMed ID: 2152861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.